Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Hosp Palliat Care. 2015 Feb;32(1):29-33. doi: 10.1177/1049909113502119. Epub 2013 Aug 23.

Identifying predictors of hospice eligibility in patients with Parkinson disease.

Author information

1
Mental Health Division, Portland Veterans Affairs Medical Center, Portland, OR, USA Elizabeth.Goy@va.gov.
2
Mental Health Division, Portland Veterans Affairs Medical Center, Portland, OR, USA.
3
Department of Neurology, Oregon Health & Science University, Portland, OR, USA.

Abstract

This study aims to improve recognition of hospice eligibility for patients with Parkinson disease (PD) by ascertaining which variables have a higher probability of occurring uniquely in 6 to 12 months before death when compared to 18 to 24 months before death. Participants were 339 patients who died who were diagnosed with PD or Parkinsonism and treated with dopaminergic prescriptions for at least 3 years in northwestern US Veterans Affairs medical centers. A range of indicators were compared across 3 time periods (30-36 months, 24-18 months, and 12-6 months before death) using within-subjects repeated measures design. Results indicate that body mass index less than 18, alone or combined with a shift in prescribing (when benefits of dopaminergic medications no longer outweigh their risk of side effects), may signal appropriate timing for hospice referral.

KEYWORDS:

Parkinson disease; hospice; palliative

PMID:
23975684
DOI:
10.1177/1049909113502119
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center